BEND, Ore. & TAMPA, Fla.--(BUSINESS WIRE)--Bend Research Inc. and Xcelience LLC announced today that the two companies have formed a collaboration to provide oral solid-solubilization formulation solutions and expedited clinical supply manufacture in combined programs to advance clients’ best new medicines. The collaboration will deliver superior value to clients with challenging drug-development candidates by combining Bend’s problem-solving and formulation/processing expertise for delivering poorly soluble compounds with Xcelience’s solid reputation for accelerating early-phase development activities. The collaboration will maximize stage-specific expertise and expand operational capacity in a manner that provides immediate streamlined solutions to clients with tight timelines for producing clinical supplies.
